Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

SEMA3G antibody (Middle Region)

SEMA3G Reactivity: Human WB, IHC (p), EIA Host: Rabbit Polyclonal unconjugated
Catalog No. ABIN954720
  • Target See all SEMA3G Antibodies
    SEMA3G (Sema Domain, Immunoglobulin Domain (Ig), Short Basic Domain, Secreted, (Semaphorin) 3G (SEMA3G))
    Binding Specificity
    • 9
    • 7
    • 6
    • 6
    • 3
    AA 223-252, Middle Region
    Reactivity
    • 28
    • 1
    Human
    Host
    • 26
    • 2
    Rabbit
    Clonality
    • 28
    Polyclonal
    Conjugate
    • 11
    • 3
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    This SEMA3G antibody is un-conjugated
    Application
    • 19
    • 15
    • 14
    • 1
    Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Enzyme Immunoassay (EIA)
    Specificity
    Recognizes SEMA3G (Center).
    Purification
    Protein A column followed by peptide Affinity purification
    Immunogen
    KLH conjugated synthetic peptide between 223-252 amino acids from the Central region of Human SEMA3G Genename: SEMA3G
    Isotype
    Ig Fraction
  • Application Notes
    Optimal working dilution should be determined by the investigator.
    Restrictions
    For Research Use only
  • Format
    Liquid
    Concentration
    0.25 mg/mL
    Buffer
    PBS with 0.09 % (W/V) Sodium Azide as preservative
    Preservative
    Sodium azide
    Precaution of Use
    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Handling Advice
    Avoid repeated freezing and thawing.
    Storage
    4 °C/-20 °C
    Storage Comment
    Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
  • Thal, Züchner, Gierer, Schulte, Schöls, Schüle, Synofzik: "Abnormal Paraplegin Expression in Swollen Neurites, τ- and α-Synuclein Pathology in a Case of Hereditary Spastic Paraplegia SPG7 with an Ala510Val Mutation." in: International journal of molecular sciences, Vol. 16, Issue 10, pp. 25050-66, (2016) (PubMed).

    Franke, Rickelt, Zimbelmann, Dörflinger, Kuhn, Frey, Heid, Rosin-Arbesfeld et al.: "Striatins as plaque molecules of zonulae adhaerentes in simple epithelia, of tessellate junctions in stratified epithelia, of cardiac composite junctions and of various size classes of lateral ..." in: Cell and tissue research, Vol. 359, Issue 3, pp. 779-97, (2015) (PubMed).

    Bailey, Xie, Do, Montpetit, Diaz, Mohan, Keavney, Yusuf, Gerstein, Engert, Anand: "Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) study." in: Diabetes Care, Vol. 33, Issue 10, pp. 2250-3, (2010) (PubMed).

    Talmud, Drenos, Shah, Shah, Palmen, Verzilli, Gaunt, Pallas, Lovering, Li, Casas, Sofat, Kumari, Rodriguez, Johnson, Newhouse, Dominiczak, Samani, Caulfield, Sever, Stanton, Shields, Padmanabhan et al.: "Gene-centric association signals for lipids and apolipoproteins identified via the HumanCVD BeadChip. ..." in: American journal of human genetics, Vol. 85, Issue 5, pp. 628-42, (2009) (PubMed).

    Karayan-Tapon, Wager, Guilhot, Levillain, Marquant, Clarhaut, Potiron, Roche: "Semaphorin, neuropilin and VEGF expression in glial tumours: SEMA3G, a prognostic marker?" in: British journal of cancer, Vol. 99, Issue 7, pp. 1153-60, (2008) (PubMed).

    Kigel, Varshavsky, Kessler, Neufeld: "Successful inhibition of tumor development by specific class-3 semaphorins is associated with expression of appropriate semaphorin receptors by tumor cells." in: PLoS ONE, Vol. 3, Issue 9, pp. e3287, (2008) (PubMed).

    Rikova, Guo, Zeng, Possemato, Yu, Haack, Nardone, Lee, Reeves, Li, Hu, Tan, Stokes, Sullivan, Mitchell, Wetzel, Macneill, Ren, Yuan, Bakalarski, Villen, Kornhauser, Smith, Li, Zhou, Gygi, Gu et al.: "Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer. ..." in: Cell, Vol. 131, Issue 6, pp. 1190-203, (2007) (PubMed).

    Howell, Shindo, Murray, Gridley, Wilson, Schimenti: "Mutation of a ubiquitously expressed mouse transmembrane protein (Tapt1) causes specific skeletal homeotic transformations." in: Genetics, Vol. 175, Issue 2, pp. 699-707, (2007) (PubMed).

    Fukuda, Mikoshiba: "Tac2-N, an atypical C-type tandem C2 protein localized in the nucleus." in: FEBS letters, Vol. 503, Issue 2-3, pp. 217-8, (2001) (PubMed).

  • Target
    SEMA3G (Sema Domain, Immunoglobulin Domain (Ig), Short Basic Domain, Secreted, (Semaphorin) 3G (SEMA3G))
    Alternative Name
    SEMA3G (SEMA3G Products)
    Synonyms
    sem2 antibody, AK129018 antibody, CSG53 antibody, RGD1306079 antibody, semaphorin 3G antibody, sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3G antibody, SEMA3G antibody, Sema3g antibody, sema3g antibody
    Background
    SEMA3G has chemorepulsive activities for sympathetic axons. Ligand of NRP2 (By similarity).Synonyms: Semaphorin sem2, Semaphorin-3G
    Gene ID
    56920
    NCBI Accession
    NP_064548
You are here:
Support